877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

aksci.com, Nootropics

Categories

Drugs acting on the nervous system (11)
Psychoactive drugs (11)
Psychoanaleptics (11)
Cyclic compounds (6)
Pharmaceuticals (6)
Six-membered rings (4)
Antidementia agents (2)
Dopamine reuptake inhibitors (2)
Five-membered rings (2)
Monoamine reuptake inhibitors (2)
Pyridines (2)
Racetams (2)
Stimulants (2)
Antiarrhythmic agents (1)
Anticonvulsants (1)
Antiparkinsonian agents (1)
Anxiolytics (1)
Aromatic amines (1)
Aromatic compounds (1)
Cholinergics (1)
D2-receptor agonists (1)
Dopamine agonists (1)
Drugs acting on the cardiovascular system (1)
Drugs by country (1)
Drugs in the Soviet Union (1)
Furans (1)
Hydroxamic acids (1)
Neuroprotective agents (1)
Piperidines (1)
Potassium channel blockers (1)
Pyrimidines (1)
Pyrrolidines (1)

Suppliers

Matrix Scientific (4)
Sigma Aldrich (4)
TCI Chemicals (3)
Frontier Scientific (2)
Oakwood Chemical (2)
Toronto Research Chemicals (2)
Apollo Scientific (1)

modafinil (68693-11-8)  
Vigil  ·  Provigil  ·  Alertec
Modafinil, sold under the brand name Provigil among others, is a wakefulness-promoting drug used for treatment of disorders such as narcolepsy, shift work sleep disorder, idiopathic hypersomnia, and excessive daytime sleepiness associated with obstructive sleep apnea. It has also seen widespread off-label use as a purported cognitive enhancer. In the United States modafinil is classified as a schedule IV controlled substance and restricted in availability and usage, due to concerns about possible addiction potential.
donepezil (120014-06-4)  
Aricept  ·  donepezil hydrochloride  ·  E2020
Donepezil, marketed under the trade name Aricept, is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease. Common side effects include loss of appetite, gastrointestinal upset, diarrhea, difficulty sleeping, vomiting, or muscle cramping.
edaravone (89-25-8)  
3-methyl-1-phenyl-2-pyrazolin-5-one  ·  MCI-186  ·  norantipyrine
Edaravone, sold as under the brand names Radicava and Radicut, is an intravenous medication used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS). The label carries a warning about the potential for hypersensitivity reactions to edaravone, and adverse effects include bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections. The mechanism by which edaravone might be effective is unknown.
aniracetam (72432-10-1)  
1-anisoyl-2-pyrrolidinone  ·  Ro 13-5057  ·  1-(4-methoxybenzoyl)-2-pyrrolidinone
Aniracetam (brand names Draganon, Sarpul, Ampamet, Memodrin, Referan), also known as N-anisoyl-2-pyrrolidinone, is a racetam which is sold in Europe as a prescription drug. It is not approved by the Food and Drug Administration for use in the United States.
ADRAFINIL (63547-13-7, 827603-92-9)  
benzhydrylsulfinylacetohydroxamic acid  ·  Olmifon  ·  CRL-40028
SN-glycero-3-phosphocholine (563-24-6, 28319-77-9)  
Glycerylphosphorylcholine  ·  Glycerophosphorylcholine  ·  Choline Glycerophosphate
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which may have potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine.
Pyrithioxin (1098-97-1)  
Pyritinol  ·  Dipyridoxolyldisulfide  ·  Pyridoxinedisulfide
Pyritinol also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of vitamin B6 (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B6 compounds (pyridoxine) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders and learning disorders in children.
Linopirdine (105431-72-9)  
3,3-bis(4-pyridylmethyl)-1-phenylindolin-2-one  ·  3,3-dipyridylmethyl-1-phenyl-2-indolinone  ·  DuP 996
Linopirdine is a putative cognition-enhancing drug with a novel mechanism of action. Linopirdine blocks the KCNQ2\3 heteromer M current with an IC50 of 2.4nM disinhibiting acetylcholine release, and increasing hippocampal CA3-schaffer collateral mediated glutamate release onto CA1 pyramidal neurons. In a murine model linopirdine is able to nearly completely reverse the senescence-related decline in cortical c-FOS, an effect which is blocked by atropine and MK-801, suggesting Linopirdine can compensate for the age related decline in acetylcholine release.
Sulbutiamine (3286-46-2)  
2-isobutyrylthiamine disulfide  ·  Surmenalit  ·  bis(2-(isobutyryloxy)ethyl-1-N-((4-amino-2-methylpyrimidin-5-yl)methyl)formamido-2-propene-1-yl)disulfide
Sulbutiamine (brand name: Arcalion) is a synthetic derivative of thiamine (vitamin B1). As a dimer of two modified thiamine molecules, it is a lipophilic compound that crosses the blood–brain barrier more readily than thiamine and increases the levels of thiamine and thiamine phosphate esters in the brain. Sulbutiamine was discovered in Japan in an effort to develop more useful thiamine derivatives since it was hoped that increasing the lipophilicity of thiamine would result in better pharmacokinetic properties.
34562-97-5 (34562-97-5)  
Picamilon (also known as N-nicotinoyl-GABA, pycamilon, and pikamilon) is a drug formed by a synthetic combination of niacin and GABA. It was developed in the Soviet Union in 1969 and further studied in both Russia and Japan as a prodrug of GABA. In Russia, picamilon is sold as a prescription drug.
Coluracetam (135463-81-9)  
Coluracetam (INN) (code name BCI-540; formerly MKC-231) is a nootropic agent of the racetam family. It was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depressive disorder (MDD), which was preceded by being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.

Related Results:
Galanthamine hydrobromide (193146-85-9, 1953-04-4)  
Galantamine  ·  Galanthamine  ·  Reminyl
piracetam (7491-74-9)  
Geram  ·  Nootropil  ·  Azupharma Brand of Piracetam
Piracetam (sold under many brand names) is a medication in the racetams group, with chemical name 2-oxo-1-pyrrolidine acetamide. It is used in Europe, Asia and South America. In the United States, it is not approved by the US Food and Drug Administration for any medical use and it is not permitted to be sold as a dietary supplement.
TETRABENAZINE (58-46-8)  
Nitoman  ·  Orphan Brand of Tetrabenazine  ·  Tetrabenazine Orphan Brand
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is marketed under the trade names Nitoman in Canada and Xenazine in New Zealand, some parts of Europe and in the United States as an orphan drug. On August 15, 2008, the U.S.
MEMANTINE HYDROCHLORIDE (41100-52-1)  
Memantine  ·  Namenda  ·  D 145
Memantine is used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors. It was first synthesized by Eli Lilly and Company in 1968 as a potential agent to treat diabetes; the NMDA activity was discovered in the 1980s.
aniracetam (72432-10-1)  
1-anisoyl-2-pyrrolidinone  ·  Ro 13-5057  ·  1-(4-methoxybenzoyl)-2-pyrrolidinone
Aniracetam (brand names Draganon, Sarpul, Ampamet, Memodrin, Referan), also known as N-anisoyl-2-pyrrolidinone, is a racetam which is sold in Europe as a prescription drug. It is not approved by the Food and Drug Administration for use in the United States.
oxiracetam (62613-82-5, 68567-97-5)  
ISF 2522  ·  ISF-2522
Oxiracetam (developmental code name ISF 2522) is a nootropic drug of the racetam family and very mild stimulant. Several studies suggest that the substance is safe even when high doses are consumed for a long period of time. However, the mechanism of action of the racetam drug family is still a matter of research.
memantine (19982-08-2)  
Namenda  ·  D 145  ·  D145
Memantine is used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors. It was first synthesized by Eli Lilly and Company in 1968 as a potential agent to treat diabetes; the NMDA activity was discovered in the 1980s.
Agomelatine (138112-76-2)  
Agomelatine (brand names Valdoxan, Melitor, Thymanax) is an atypical antidepressant developed by the pharmaceutical company Servier. It is marketed for the treatment of major depressive disorder, primarily for its relatively favorable side effect profile: it avoids the weight gain, sexual dysfunction, and severe withdrawal associated with the most commonly used classes of antidepressants (SSRIs, SNRIs, tricyclics), while providing similar therapeutic benefit. Due to its distinctive mechanism of action, agomelatine is also studied for its effects on sleep regulation.
nicergoline (27848-84-6)  
Nicergolin neuraxpharm  ·  ergobel  ·  Krewel Brand of Nicergoline
Nicergoline (INN, marketed under the trade name Sermion) is an ergot derivative used to treat senile dementia and other disorders with vascular origins. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs.
Related searches
aksci.com
Nootropics
Next Page >